EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 23, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Interventions
DEVICE

EktoTherix

The EktoTherix scaffold is applied to the fresh wound resulting from a full thickness excision of non-melanoma skin cancer and then bolstered by the application of a non-adhesive foam dressing (discontinued at the first visit); both scaffold and foam dressing are secured in place using a semi-occlusive film dressing. The EktoTherix-treated wound is assessed weekly as per standard of care.

Trial Locations (3)

TS4 3BW

The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough

YO12 6QL

Scarborough Hospital, York Teaching Hospital NHS Foundation Trust, Scarborough

YO31 8HE

The York Hospital, York Teaching Hospital NHS Foundation Trust, York

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Lorien Engineering Solutions (a division of GP Strategies Ltd)

UNKNOWN

collaborator

Smith & Nephew Advanced Wound Management

UNKNOWN

collaborator

NAMSA

OTHER

collaborator

Innovate UK

OTHER_GOV

lead

Neotherix Limited

INDUSTRY